Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors
Marharyta Kolcheva, Štěpán Kortus, Barbora Hrčka Krausová, et al.
Neuropharmacology (2021) Vol. 189, pp. 108528-108528
Closed Access | Times Cited: 19

Showing 19 citing articles:

De novo GRIN variants in M3 helix associated with neurological disorders control channel gating of NMDA receptor
Yuchen Xu, Rui Song, Riley E. Perszyk, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 9
Morphing cholinesterase inhibitor amiridine into multipotent drugs for the treatment of Alzheimer's disease
Eva Mezeiová, Lukáš Prchal, Martina Hrabinová, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116399-116399
Open Access | Times Cited: 5
Disease-Associated Variants in GRIN1, GRIN2A and GRIN2B genes: Insights into NMDA Receptor Structure, Function, and Pathophysiology
Michal Korinek, M C Serra, Fes Abdel Rahman, et al.
Physiological Research (2024), Iss. Suppl 1, pp. S413-S434
Open Access | Times Cited: 4
Pro-cognitive effects of dual tacrine derivatives acting as cholinesterase inhibitors and NMDA receptor antagonists
Markéta Chvojková, David Kolář, Katarina Kovacova, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116821-116821
Open Access | Times Cited: 3
Grin1Y647S/+ Mice: A Preclinical Model of GRIN1-Related Neurodevelopmental Disorder
Megan T. Sullivan, Patrick Tidball, Yuanye Yan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
The pathogenic N650K variant in the GluN1 subunit regulates the trafficking, conductance, and pharmacological properties of NMDA receptors
Marharyta Kolcheva, Marek Ladislav, Jakub Netolický, et al.
Neuropharmacology (2022) Vol. 222, pp. 109297-109297
Open Access | Times Cited: 13
Potent and reversible open-channel blocker of NMDA receptor derived from dizocilpine with enhanced membrane-to-channel inhibition
Anna Misiachna, Jan Konečný, Marharyta Kolcheva, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117201-117201
Open Access | Times Cited: 2
Protein quality control of N-methyl-D-aspartate receptors
Taylor M. Benske, Ting‐Wei Mu, Yajuan Wang
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 10
GRIN1 variants associated with neurodevelopmental disorders reveal channel gating pathomechanisms
Lotten Ragnarsson, Zihan Zhang, Sooraj S. Das, et al.
Epilepsia (2023) Vol. 64, Iss. 12, pp. 3377-3388
Open Access | Times Cited: 5
Subunit-Dependent Surface Mobility and Localization of NMDA Receptors in Hippocampal Neurons Measured Using Nanobody Probes
Štěpán Kortus, Kristyna Rehakova, Martin Klíma, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 26, pp. 4755-4774
Open Access | Times Cited: 4
Structure-Guided Design of N-Methylpropargylamino-Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer’s Disease
Barbora Svobodová, Lenka Pulkrabkova, Dawid Panek, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9124-9124
Open Access | Times Cited: 2
Morphing Cholinesterase Inhibitor Amiridine into Multipotent Drugs for the Treatment of Alzheimer's Disease
Eva Mezeiová, Lukáš Prchal, Martina Hrabinová, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Potent and reversible open-channel blocker of NMDA receptor derived from dizocilpine with enhanced membrane-to-channel inhibition
Anna Misiachna, Jan Konečný, Marharyta Kolcheva, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Dizocilpine derivatives with neuroprotective effect lacking the psychomimetic side effects
Jan Konečný, Anna Misiachna, Markéta Chvojková, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Dizocilpine derivatives as neuroprotective NMDA receptor antagonists without psychomimetic side effects
Jan Konečný, Anna Misiachna, Markéta Chvojková, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116981-116981
Open Access
Context matters: Integrative NMDA receptor dysfunction reveals effective seizure treatment in mice with a human patient GluN1 variant
Sridevi Venkatesan, Daria Nazarkina, Megan T. Sullivan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Pro-cognitive Effects of Dual Tacrine Derivatives Acting as Cholinesterase Inhibitors and NMDA Receptor Antagonists
Markéta Chvojková, David Kolář, Katarina Kovacova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Memantine protects the cultured rat hippocampal neurons treated by NMDA and amyloid β1–42
Nataliia M. Rozumna, Vita V. Hanzha, E. A. Lukyanetz
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 1
An integrated approach to evaluate the functional effects of disease-associated NMDA receptor variants
Gabrielle Moody, A Musco, Joseph Bennett, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top